Trial Profile
Effect of Interferon Beta-1a SC 44 µg Three Times Weekly (Tiw) (Rebif) and Dimethyl Fumarate (DMF, Tecfidera) on Infections and Lymphocytes in Patients 50 Years or Older From a Single Center Chart Review
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors EMD Serono Research & Development Institute
- 12 Oct 2018 Results presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
- 03 Aug 2018 Status changed from recruiting to completed.
- 09 Feb 2018 Planned End Date changed from 31 Dec 2017 to 31 Jul 2018.